Scientific and administrative leadership and effective program project management of the HIVRAD is the goal of Core A. The core will oversee scientific progress relative to project aims and milestones and lead scientific efforts in conjunction with the Executive Committee and Scientific Advisory Board. It will coordinate financial management, research program management, regulatory compliance and reporting functions. In addition to coordinating these activities, the Administrative Core will be responsible for promoting and documenting all aspects of scientific, IACUC and financial regulatory compliance at Penn and subcontracting institutions. Staff on this core are located within the administrative offices of Dr. Shaw, thus taking advantage of a highly experienced and integrated management team. The University of Pennsylvania provides infrastructure support for administration, information technology, and human resources, and also provides dedicated pre- and post- award units to expedite the work. Penn will provide this support for the HIVRAD. A highly functional administrative core will contribute to and facilitate the successful advancement of the proposed science.
Specific aims of Core A are to: (i) provide scientific and administrative leadership and program coordination; (ii) ensure timely financial accounting and reporting; (iii) ensure regulatory compliance with all institutional and federal research guidelines; and (iv) develop and implement an HIVRAD communications and data sharing plan.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI131251-02
Application #
9447112
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Wagh, Kshitij; Kreider, Edward F; Li, Yingying et al. (2018) Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth. Cell Rep 25:893-908.e7
Fera, Daniela; Lee, Matthew S; Wiehe, Kevin et al. (2018) HIV envelope V3 region mimic embodies key features of a broadly neutralizing antibody lineage epitope. Nat Commun 9:1111
Song, Hongshuo; Giorgi, Elena E; Ganusov, Vitaly V et al. (2018) Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection. Nat Commun 9:1928
Richard, Jonathan; Prévost, Jérémie; Baxter, Amy E et al. (2018) Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses. MBio 9:
LaBranche, Celia C; McGuire, Andrew T; Gray, Matthew D et al. (2018) HIV-1 envelope glycan modifications that permit neutralization by germline-reverted VRC01-class broadly neutralizing antibodies. PLoS Pathog 14:e1007431
Prévost, Jérémie; Richard, Jonathan; Ding, Shilei et al. (2018) Envelope glycoproteins sampling states 2/3 are susceptible to ADCC by sera from HIV-1-infected individuals. Virology 515:38-45
Williams, Wilton B; Zhang, Jinsong; Jiang, Chuancang et al. (2017) Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations. Nat Commun 8:1732
Saunders, Kevin O; Verkoczy, Laurent K; Jiang, Chuancang et al. (2017) Vaccine Induction of Heterologous Tier 2 HIV-1 Neutralizing Antibodies in Animal Models. Cell Rep 21:3681-3690
Silva, Murillo; Nguyen, Thao H; Philbrook, Phaethon et al. (2017) Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes. Cell Rep 21:3672-3680
Roberts, Emily R; Carnathan, Diane G; Li, Hui et al. (2016) Collapse of Cytolytic Potential in SIV-Specific CD8+ T Cells Following Acute SIV Infection in Rhesus Macaques. PLoS Pathog 12:e1006135